Results 111 to 120 of about 1,142,872 (298)
Mapping the Social Network Structure and Composition of Black Individuals With Rheumatic and Musculoskeletal Conditions
Arthritis Care &Research, EarlyView.Objective
Our objective was to describe the social networks of Black individuals with rheumatic and musculoskeletal conditions and understand the clustering of health‐related behaviors to inform future community‐based, peer‐led interventions. Methods
We used an adapted Personal Network Survey for Clinical Research (PERSNET) to map the personal social ...Taussia Boadi, Amar Dhand, Leah Santacroce, Neil Pillai, Komel Safdar, Mia T. Chandler, Ariel Childs, Monica Crespo‐Bosque, Gina Curry, Mary Dollear, Alice Eggleston, Daniel Erickson, Dieufort Fleurissaint, Denice Garrett, Gail Granville, Tyler Green, Magdalena Hamielec, Elena Losina, Karen Mancera‐Cuevas, Mary Ann Nelson, Chisa Nosamiefan, Bisola Ojikutu, Tonya S. Roberson, Mary Beth Son, Marie Jacques Toussaint, Michael York, Rosalind Ramsey‐Goldman, Candace H. Feldman +27 morewiley +1 more sourceHow Rapidly Should Remission Be Achieved?
, 2010 The major goal of therapy in inflammatory bowel disease is to induce remission. Remission has multiple definitions – clinical remission, where the patient’s symptoms have remitted, and endoscopic remission, in which there has been complete mucosal ...Kim L. Isaacscore +1 more sourceIncidence, Risk Factors, and Management of Adverse Events in Contemporary, Real‐World Care of Children With Juvenile Idiopathic Arthritis
Arthritis Care &Research, EarlyView.Objective
We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAEs and SAEs) in children with newly diagnosed juvenile idiopathic arthritis (JIA) in Canada. Methods
We enrolled patients within three months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI ...Bashayer Alnuaimi, Roberta A. Berard, Jean‐Philippe Proulx‐Gauthier, Heinrike Schmeling, Michelle Batthish, Gilles Boire, Adam M. Huber, Dax G. Rumsey, Jaime Guzman, Gaëlle Chédeville, for the Canadian Alliance of Pediatric Rheumatology Investigators, David A. Cabral, Gaëlle Chédeville, Ciaran M. Duffy, Kerstin Gerhold, Jaime Guzman, Linda Hiraki, Adam M. Huber, Heinrike Schmeling, Natalie J. Shiff, Lori B. Tucker, Julie Barsalou, Daniah Basodan, Michelle Batthish, Roberta A. Berard, Lyne Bissonnette, Nicholas Blanchette, Gilles Boire, Roxana Bolaria, Alessandra Bruns, Sarah Campillo, Tania Cellucci, Mercedes Chan, Amieleena Chhabra, Julie Couture, Paul Dancey, Jean‐Jacques De Bruycker, Erkan Demirkaya, Muhammed Dhalla, Molly Dushnicky, Janet Ellsworth, Talal El Tal, Brian M. Feldman, Tommy Gerschman, Liane Heale, Julie Herrington, Kristin M. Houghton, Andrea Human, Clare Hutchinson, Mehul Jariwala, Nicole Johnson, Roman Jurencak, Ronald M. Laxer, Piya Lahiry, Bianca Lang, Claire LeBlanc, Jennifer Lee, Deborah M. Levy, Lillian Lim, Lily S. H. Lim, Elizaveta Limenis, Nadia Luca, Jo‐Anne Marcuz, Jeanine McColl, Tara McGrath, Tamara McMillan, Megan McPherson, Paivi Miettunen, Kimberly Morishita, Honyan Ng, Jonathan Park, Jean‐Philippe Proulx‐Gauthier, Johannes Roth, Evelyn V. Rozenblyum, Dax G. Rumsey, Christian Scott, Rosie Scuccimarri, Gordon Soon, Lynn Spiegel, Rebeka Stevenson, Elizabeth Stringer, Herman Tam, Justine Turmel‐Roy, Shirley M. L. Tse, Marinka Twilt, Ruud H. J. Verstegen, Karen Watanabe Duffy, Kristi Whitney, Stephanie Wong +88 morewiley +1 more sourceLong-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
, 2020 Biannual rituximab infusions over 18 months effectively maintain remission after a “standard” remission induction regimen for patients with antineutrophil cytoplasmic antibody–associated vasculitis ...Carron, Pierre-Louis, Gobert, Pierre, Le Gallou, Thomas, Martin-Silva, Nicolas, Karras, Alexandre, Lifermann, François, Mouthon, Luc, Agard, Christian, Pugnet, Grégory, Perrodeau, Élodie, Huart, Antoine, Sibilia, Jean, Viallard, Jean-François, Meaux-Ruault, Nadine, Néel, Antoine, Hanrotel-Saliou, Catherine, Maurier, François, Hachulla, Eric, Puéchal, Xavier, Charles, Pierre, Bonnotte, Bernard, Cohen, Pascal, Godmer, Pascal, Vinzio, Stéphane, Guillevin, Loïc, Ravaud, Philippe, Samson, Maxime, Vinter, Christine, Terrier, Benjamin +28 morecore +1 more sourceReal‐World Effectiveness and Safety of Secukinumab in Giant Cell Arteritis: An Italian Multicenter Cohort Study
Arthritis Care &Research, EarlyView.Objective
The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods
This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.Luca Iorio, Federica Davanzo, Caterina Ricordi, Milena Bond, Ruggiero Mascolo, Jacopo Mora, Alessandro Tomelleri, Angelo Fassio, Francesca Cuzzocrea, Sara Monti, Edoardo Conticini, Fabiola Atzeni, Paolo Delvino, Carlotta Nannini, Augusta Ortolan, Francesco Pollastri, Ester Vivaldelli, Chiara Marvisi, Paola Toniati, Antonio Brucato, Alessandra Milanesi, Francesca Regola, Enrico Tombetti, Lorenzo Dagna, Roberta Ramonda, Christian Dejaco, Luca Quartuccio, Carlo Salvarani, Roberto Padoan +28 morewiley +1 more sourceAdalimumab Induces Deep Remission in Patients With Crohn's Disease
, 2014 Patients with moderate to severe ileocolonic Crohn's disease (CD) who received adalimumab induction and maintenance therapy had greater rates of mucosal healing than patients who received placebo after adalimumab induction therapy in a 52-week trial ...Sandborn, William J., Mulani, Parvez M., Thakkar, Roshni, Colombel, Jean–Frédéric, Robinson, Anne M., Chao, Jingdong, Thakkar, Roopal B., Chen, Naijun, Rutgeerts, Paul J., Yang, Mei, Camez, Anne, Pollack, Paul F. +11 morecore +1 more sourcePatients Improve, Patterns Persist: Longitudinal Stability of Rheumatoid Arthritis Joint Involvement Patterns
Arthritis Care &Research, EarlyView.Objective
Rheumatoid arthritis is a heterogeneous disease. Data‐driven approaches, from synovial histology to joint involvement patterns (JIPs), have sought to define clinically meaningful subgroups. Whether these subgroups represent stable phenotypes or transient disease states remains unclear.Tjardo Maarseveen, Yasuo Nagafuchi, Kristina Lend, Seyam Alemyar, Herman Kasper Glas, Gerdur Gröndal, Bjorn Gudbjornsson, Espen A. Haavardsholm, Kim Hørslev Petersen, Jon Lampa, Merete Lund Hetland, Dan Nordström, Mike Nurmohamed, Mikkel Østergaard, Anna Rudin, Marte Schrumpf Heiberg, Tuulikki Sokka‐Isler, Till Uhlig, Josien van Dieren, Ronald van Vollenhoven, Tom Huizinga, Marcel J. T. Reinders, Sytske Anne Bergstra, Erik van den Akker, Rachel Knevel +24 morewiley +1 more sourceMESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS
Медицинский совет, 2017 Preparations of 5-aminosalycil acid (Mesalazine) are used as the first-line therapy to induce remission if the UC activity is minimal and as the priority drugs for anti-recurrence therapy of patients with UC and are included in the Russian ...I. G. Bakulin, M. I. Skalinskaya, E. V. Skazyvaeva +2 moredoaj +1 more source